Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

NCT04346667 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

125

Enrollment

OTHER_GOV

Sponsor class

Stopped Poor accrual.

Conditions

SARS-CoV-2
Coronavirus Infection
Asymptomatic Condition
COVID-19

Interventions

DRUG: Hydroxychloroquine Sulfate Regular dose
DRUG: Hydroxychloroquine Sulfate Loading Dose
DRUG: Chloroquine
DRUG: Placebo

Sponsor

Government of Punjab, Specialized Healthcare and Medical Education Department

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]